У нас вы можете посмотреть бесплатно What patients need to know about antiamyloid monoclonal antibodies for Alzheimer’s disease или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
There are 2 antiamyloid monoclonal antibody drugs now available for the treatment of mild cognitive impairment or mild Alzheimer’s disease. Patients and families need to be familiar with efficacy of these drugs, expected outcomes, potential side effects, and monitoring requirements before making the decision to start these therapies. Dr. David Weisman reviews which patients are eligible, efficacy, safety, and long-term monitoring for these drugs. ExchangeCME.com is an online community of more than 60,000 active healthcare professionals who have access to a variety of enduring educational activities and other disease state–focused resources. The Website’s core mission is to support patient-centered care via education that is tailored to the needs of various clinician audiences. By consolidating evidence-based resources and hosting only accredited educational programs without any promotional content or advertising, ExchangeCME.com serves as an independent, trusted, and balanced source of free CME/CE for physicians, nurses, pharmacists, and other healthcare providers. #CME #alzheimers #alzheimerscaregiver #alzheimerscare #alzheimer #alzheimerawareness #alzheimersdisease ADXHA4P